We’re now just mere days away from this year’s BioData World Congress, the world’s leading event for individuals working with Big Data.
The annual event, held with the support of the Sanger Institute, the EBI, the Global Alliance for Genomics and Health and The Pistoia Alliance, aims to showcase innovation, demonstrate success and break through any barriers to ensure innovations in genomics get to the patient with speed and efficiency.
To get you ready for the excitement of this year’s event, we look back at the key takeaways from Bob Rogers’, Chief Data Scientist for Analytics and AI Solutions at Intel Corporation, keynote presentation last year and assess the direction this year’s conference may take.
Data utilization – True State of the Patient
As an industry we need to collectively improve the way we acquire, order, analyze and utilize the myriad of data types generated across the healthcare ecosystem.
With a wide range of different data sets available, such as clinical, behavioral and genomic data, establishing a computable model of the patient, or True State, will help optimize care delivery, outcomes and revenue.
At this year’s conference the relationship between Big Data and genomics is set to be discussed in-depth across both days, alongside the quest to deliver personalized medicine.
Data efficiency lies at the heart of this issue. Heath and Life Sciences organizations need to ensure the data they hold is utilized in the right way if they are to capitalize on emerging opportunities and technology which can help provide greater care.
It is hard to escape wearable technology – it’s now mainstream. In recent years, devices have become more affordable, easy to use and are increasingly capturing vast amounts of data. Whilst the rate of adoption is accelerating and revealing more opportunities to improve the provision of care - estimates for wearable tech sales in 2016 are around 102 million - there is an issue around whether or not data can be recorded correctly, interpreted and relayed back in a useful manner. This confidence issue is shared by both patients and healthcare providers.
Understanding how wearable technology fits into the wide IT infrastructure and how it will shape the way care is administered remains a topic for debate. However, the same concerns about data management remain.
Adopting new devices is all well and good, but if the infrastructure to support them doesn’t exist, they may hinder the provision of existing services.
The data challenge
As outlined in Rogers’ presentation last year, organizations are taking their approach to data seriously and increasingly investing in ways to maximize the value it can provide. Whilst a number of issues remain, there appears to be a far greater focus on how data can and should be applied.
The True State of the Patient is becoming a less than distant reality. Last year, the foundations for achieving a far sharper view of the patient emerged and this year’s conference and focus on the partnership between Big Data and genomics looks set to advance the industry further in the right direction.
To find out more about how Intel can support your organization, help you consolidate your data assets and understand which systems can help process genomic data and deliver analytic results, be sure to attend Michael McManus’, Senior Health & Life Sciences Solution Architect, Intel Corporation, opening keynote presentation on The future impact on “sequencing everyone”.
To find out more about this year’s programme visit the conference website here.
If you want to join as at BioData World Congress then you can use code WQPG to get 15% off.
We will be producing a follow up blog post highlighting some of the key takeaways and points of discussion. Check back on our blog after the event to see this post and get in touch with our team if you have questions or want to find out more.